Partner John T. Crutchlow
Partner John T. Crutchlow

John T. Crutchlow


John T. Crutchlow is a former federal prosecutor who represents whistleblowers and a wide range of clients in high stakes civil litigation.  Crutchlow joined Youman & Caputo following more than a decade fighting fraud for the federal government as a civil Assistant United States Attorney with the U.S. Department of Justice (DOJ) and as a Trial Attorney with the Enforcement Division of the Securities and Exchange Commission (SEC). 

Crutchlow represents whistleblowers in qui tam actions under the False Claims Act when they have information about fraud on government programs, including misconduct in the healthcare and pharmaceutical industries impacting Medicare, Medicaid, or Tricare, fraud on federal grant programs, and fraud in federal contracts and procurement.  

He also represents SEC whistleblowers with information about securities law violations, and whistleblowers in cases under the Commodity Futures Trading Commission and IRS whistleblower programs. 


Crutchlow brings a unique depth of knowledge to representing whistleblowers and civil litigants gained from his extensive experience within the DOJ and the SEC.  From 2011 until 2021, John was an Assistant United States Attorney (AUSA) in the Civil Division of the U.S. Attorneys Office for the Eastern District of Pennsylvania, where he focused on civil litigation and investigating fraud on federal programs, with a focus on health care fraud, under the False Claims Act, the Anti-Kickback Statute, and the Controlled Substances Act. In 2018, Crutchlow was appointed to be the team leader of the U.S. Attorneys Offices first Affirmative Civil Enforcement Strike Force, a dedicated unit of civil prosecutors that focused on False Claims Act and other civil enforcement efforts.  

As an AUSA, Crutchlow successfully led numerous investigations of entities and individuals in the healthcare industry, including pharmaceutical companies, pharmacies, durable medical equipment distributors, hospital systems, medical monitoring companies, home health agencies, medical practices, individual practitioners, and others. These cases have collectively returned tens of millions of dollars to federal programs, and many of them were initiated by whistleblowers under the qui tam provisions of the False Claims Act.  

As a Trial Attorney in the Enforcement Division of the Securities Exchange Commission from 2021 until 2023, Crutchlow litigated cases in federal court against defendants accused of violating the securities laws.  He was a member of two SEC trial teams that won verdicts from federal juries in 2022.  

Crutchlow has been repeatedly recognized for his work.  He played a leading role on a team that received an Honor Award for Advancing Excellence and Innovation in Investigations from the U.S. Department of Health and Human Services, Office of Inspector General, for successfully investigating a complex $100 million medical device fraud scheme.  Crutchlow also received a Director’s Award for Superior Performance from the Executive Office of U.S. Attorneys, and a Commendation awarded by the DOJ’s Civil Rights Division for his work enforcing the Americans with Disabilities Act. 

Crutchlow began his career as a litigation associate at Duane Morris LLP, a large international law firm based in Philadelphia.  He is a 2005 magna cum laude graduate of Villanova University School of Law and a graduate of Villanova University.